Abstract
Allergic rhinitis (AR) is considered to be multifactorial inflammatory diseases involving complex interactions between genetic and environmental influences. Inflammatory reactions in AR are regulated by many cytokines. The impact of genetic factors on the pathogenesis of AR is currently an area of intense investigation. Various loci and candidate genes have been suggested to underlie allergy. Many or all are still controversial. No significant evidence for linkage to AR has been shown so far, although significant evidence for linkage to various allergic diseases. The aim of this review was to investigate whether the genetic polymorphisms were associated with AR in the literature.
Keywords: Allergic rhinitis, genetic, polymorphism
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Genetic Polymorphism in Allergic Rhinitis
Volume: 7 Issue: 1
Author(s): Yusuf Vayisoglu and Murat Unal
Affiliation:
Keywords: Allergic rhinitis, genetic, polymorphism
Abstract: Allergic rhinitis (AR) is considered to be multifactorial inflammatory diseases involving complex interactions between genetic and environmental influences. Inflammatory reactions in AR are regulated by many cytokines. The impact of genetic factors on the pathogenesis of AR is currently an area of intense investigation. Various loci and candidate genes have been suggested to underlie allergy. Many or all are still controversial. No significant evidence for linkage to AR has been shown so far, although significant evidence for linkage to various allergic diseases. The aim of this review was to investigate whether the genetic polymorphisms were associated with AR in the literature.
Export Options
About this article
Cite this article as:
Vayisoglu Yusuf and Unal Murat, Genetic Polymorphism in Allergic Rhinitis, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (1) . https://dx.doi.org/10.2174/187152308783769195
DOI https://dx.doi.org/10.2174/187152308783769195 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Accelerated Cytotoxicity Mechanism Screening Using Drug Metabolising Enzyme Modulators
Current Drug Metabolism The Potential Role of Erythropoietin as a Pleiotropic Agent in Post-cardiac Arrest Syndrome
Current Pharmaceutical Design The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics
Current Pharmaceutical Design A Mechanistic Overview on Male Infertility and Germ Cell Cancers
Current Pharmaceutical Design Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4
Current Pharmaceutical Design Pharmacologic Targeting of Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets Genomic Expression in the Epileptogenic Hippocampus and Psychiatric Co-Morbidities
Current Psychiatry Reviews Oxidative Stress, Redox Signaling and Cancer Chemoresistance: Putting Together the Pieces of the Puzzle
Current Medicinal Chemistry Conformational Diseases and Structure-Toxicity Relationships: Lessons from Prion-Derived Peptides
Current Protein & Peptide Science Chemokines as Potential Therapeutic Targets in Atherosclerosis
Current Drug Targets Heme Oxygenase-1 in Vascular Smooth Muscle Cells Counteracts Cardiovascular Damage Induced by Angiotensin II
Current Neurovascular Research The Role of Thrombomodulin in Atherosclerosis: From Bench to Bedside
Cardiovascular & Hematological Agents in Medicinal Chemistry Serotonergic System and Its Role in Epilepsy and Neuropathic Pain Treatment: A Review Based on Receptor Ligands
Current Pharmaceutical Design Down Regulation of Differentiated Embryo-Chondrocyte Expressed Gene 1 is Related to the Decrease of Osteogenic Capacity
Current Drug Targets Physiological Basis for Contractile Dysfunction in Heart Failure
Current Pharmaceutical Design Pharmaceutical Approaches for Optimizing Oral Anti-Inflammatory Delivery Systems
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibiting the Enzymes of the Endothelin and Renin-Angiotensin Systems in Cancer
Current Enzyme Inhibition Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Therapeutic Approach for Neuronal Disease by Regulating Reninangiotensin System
Current Hypertension Reviews T Cell Tuning for Tumour Therapy: Enhancing Effector Function and Memory Potential of Therapeutic T cells
Current Gene Therapy